Peptides / FOXO4-DRI / United States
FOXO4-DRI in the United States
Legal status, what it is, and the listed suppliers in the United States that list it.
Legal status in the United States
Not an approved medicine.
As understood at 2026-09-22. Verify with the FDA.
What FOXO4-DRI is
FOXO4-DRI is a synthetic peptide designed in 2017 by a group at Erasmus MC in the Netherlands to kill senescent cells, the damaged cells that stop dividing but accumulate with age. It copies a stretch of the FOXO4 protein but is built from D-amino acids in reverse order, which makes it resistant to breakdown, and carries a cell-penetrating tag. It is a research compound; no human trials have been published.
Listed suppliers in the United States
2 of the 10 suppliers we list in the United States list FOXO4-DRI. Listed, not endorsed: each row is the supplier’s own stated terms.
BioLongevity Labs
United States
All products are manufactured for research use only. Research Use Only products sold here are intended solely for laboratory research.
Nationwide Peptides
United States
For Research Use Only. Products are not intended for human or animal consumption, ingestion, injection, or any form of administration.